| Control | DR | DR with normal BCVA (G1) | DR with decreased BCVA (G2) | P value | ||
---|---|---|---|---|---|---|---|
All groups | Control vs. DR | G1 vs. G2 | |||||
Population characteristics (n = 89) | |||||||
 No. of participants, n | 33 | 89 | 53 | 36 | NA | NA | NA |
 Age (years) | 56.94 ± 7.32 | 54.66 ± 10.95 | 50.72 ± 9.43 | 60.47 ± 10.55 |  < 0.001a | 0.960a |  < 0.001a |
 Sex (M/F) | 12/21 | 54/35 | 36/17 | 18/18 | 0.014b | 0.017b | 0.089b |
 BMI (kg/m2) | 24.57 ± 2.49 | 25.40 ± 3.67 | 25.56 ± 3.35 | 25.16 ± 4.15 | 0.433a | 0.452a | 0.598a |
 MAP (mmHg) | 92.42 ± 10.61 | 96.41 ± 22.61 | 96.78 ± 24.11 | 95.82 ± 20.29 | 0.079c | 0.372c | 1.000c |
 DM duration (years) | NA | 9.06 ± 6.34 | 7.62 ± 5.27 | 11.19 ± 7.21 | NA | NA | 0.021c |
 BG (mmol/L) | NA | 7.78 ± 2.64 | 7.42 ± 2.46 | 8.35 ± 2.83 | NA | NA | 0.067a |
Ocular characteristics (n = 132) | |||||||
 No. of eyes, n | 33 | 132 | 88 | 44 | NA | NA | NA |
 BCVA (logMAR) |  − 0.05 ± 0.05 | 0.01 ± 0.12 |  − 0.05 ± 0.06 | 0.12 ± 0.14 |  < 0.001c | 0.008c |  < 0.001c |
 SE (D) | 0.16 ± 1.16 |  − 0.10 ± 1.39 |  − 0.13 ± 1.42 | 0.21 ± 1.27 | 0.009c | 0.071c | 0.038c |
 IOP (mmHg) | 12.53 ± 2.42 | 14.41 ± 3.48 | 14.20 ± 3.53 | 14.83 ± 3.37 | 0.012a | 0.005a | 0.306a |
DR severity | |||||||
  ETDRS 20 (n = 56) | NA | 56 | 39 | 17 | NA | NA | 0.534b |
  ETDRS 35 (n = 52) | NA | 52 | 33 | 19 | NA | NA | 0.529b |
  ETDRS 43–53 (n = 24) | NA | 24 | 16 | 8 | NA | NA | 1.000b |